2096 (2096) News
Track canonical SquawkNews coverage tagged to 2096, 2096. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Roche to pay Simcere $75 million upfront for blood cancer drug rights
Roche will pay $75 million upfront to Simcere Pharmaceutical Group for rights to an experimental blood cancer drug, Simcere said Tuesday.
EQUITY | Sep 01, 2026, 11:02 AM UTC
M
Simcere Pharmaceutical signs exclusive global licensing deal for SIM0660
Simcere Pharmaceutical Group entered an exclusive global licensing agreement with Roche for SIM0660, according to TradingView News.
EQUITY | Sep 01, 2026, 10:26 AM UTC